ISCADOR oak mistletoe Qu series 0 solution for injection
Active ingredients:
ISCADOR contains as active ingredient a fermented aqueous extract from the fresh mistletoe plant (Viscum album L.) from various host trees; partly also with metal additives.
Area of application:
According to the anthroposophical knowledge of humans and nature. For adults, this includes: stimulating formal and integrative forces for the dissolution and reintegration of independent growth processes, e.g.:
Active ingredients:
ISCADOR contains as active ingredient a fermented aqueous extract from the fresh mistletoe plant (Viscum album L.) from various host trees; partly also with metal additives.
Area of application:
According to the anthroposophical knowledge of humans and nature. For adults, this includes: stimulating formal and integrative forces for the dissolution and reintegration of independent growth processes, e.g.:
- with malignant tumor diseases, also with accompanying disorders of the blood-forming organs;
- in benign tumor diseases;
- with defined precancerous lesions;
- for the prevention of recurrence after tumor operations.
For ISCADOR oak mistletoe Qu Series information on risks and side effects, read the package insert and ask your doctor or pharmacist.
Anthroposophic medicine for the extended treatment of tumor diseases.
ISCADOR oak mistletoe Qu Series Active ingredients
- 0.05 mg oak mistletoe extract (1: 5) fermented; Extracting agent: water
- 0.5 mg mistletoe extract (1: 5) fermented; Extracting agent: water
- 5 mg mistletoe extract (1: 5) fermented; Extracting agent: water
ISCADOR oak mistletoe Qu Series Auxiliary materials
- Sodium chloride
- Sodium chloride
- Water for injections
- Water for injections
- Sodium chloride
- Water for injections
Areas of application
According to the anthroposophical knowledge of man and nature, Iscador® Qu is used to stimulate the formative and integrative forces of adults to dissolve and reintegrate independent growth processes, e.g.
- with malignant tumor diseases, also with accompanying disorders of the blood-forming organs;
- in benign tumor diseases;
- to prevent tumor recurrences after operations;
- with defined preliminary stages of cancer (precancerous lesions).